Chronic systemic inflammation, characterized by elevated pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), serves as a pivotal intermediary between sarcopenia and cardiovascular complications [98]. This evidence concerns the gene IL6 and sarcopenia.